Nano-liposomes of lycopene reduces ischemic brain damage in rodents by regulating iron metabolism

Free Radical Biology and Medicine

Volumn 124, Issue , 2018, Pages 1-11

  Zhao, Yashuo ^a,b   Xin, Zhen ^a   Li, Nina ^c   Chang, Shiyang ^a   Chen, Yandong ^a   Geng, Lina ^c   Chang, Hengrui ^d   Shi, Honglian ^e   Chang, Yan Zhong ^a  

^a HEBEI NORMAL UNIVERSITY   (China)

^b HEBEI UNIVERSITY OF CHINESE MEDICINE   (China)

^c HNU   (China)

^d HEBEI MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF KANSAS   (United States)

Author keywords

Hepcidin; Iron metabolism; Lycopene; Nanoparticles; Neuroprotection; Stroke

Indexed keywords

CASPASE 3; FERROPORTIN 1; HEPCIDIN; INTERLEUKIN 6; LIPOSOME; LYCOPENE; MITOGEN ACTIVATED PROTEIN KINASE; NANOLIPOSOME; NITRIC OXIDE SYNTHASE; PROTEIN BCL 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; ANTIOXIDANT; IRON; NANOMATERIAL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; ENZYME INHIBITION; IRON METABOLISM; METABOLIC REGULATION; NERVE CELL NECROSIS; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; RODENT MODEL; SPRAGUE DAWLEY RAT; TREATMENT DURATION; ANIMAL; CHEMISTRY; MALE; METABOLISM; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; IRON; LIPOSOMES; LYCOPENE; MALE; NANOSTRUCTURES; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 85048468086     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2018.05.082     Document Type: Article

References (68)

1. Moskowitz, M.A., Lo, E.H., Iadecola, C., The science of stroke: mechanisms in search of treatments. Neuron 67 (2010), 181–198.
2. Green, A.R., Ashwood, T., Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers. Curr. Drug Targets CNS Neurol. Disord. 4 (2005), 109–118.
3. Hu, X., Zhang, M., Leak, R.K., Gan, Y., Li, P., Gao, Y., Chen, J., Delivery of neurotherapeutics across the blood brain barrier in stroke. Curr. Pharm. Des. 18 (2012), 3704–3720.
4. Di Mascio, P., Kaiser, S., Sies, H., Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch. Biochem. Biophys. 274 (1989), 532–538.
5. Sachdeva, A.K., Chopra, K., Lycopene abrogates Abeta(1-42)-mediated neuroinflammatory cascade in an experimental model of Alzheimer's disease. J. Nutr. Biochem. 26 (2015), 736–744.
6. Prema, A., Janakiraman, U., Manivasagam, T., Thenmozhi, A.J., Neuroprotective effect of lycopene against MPTP induced experimental Parkinson's disease in mice. Neurosci. Lett. 599 (2015), 12–19.
7. Karppi, J., Laukkanen, J.A., Sivenius, J., Ronkainen, K., Kurl, S., Serum lycopene decreases the risk of stroke in men: a population-based follow-up study. Neurology 79 (2012), 1540–1547.
8. Li, X., Xu, J., Dietary and circulating lycopene and stroke risk: a meta-analysis of prospective studies. Sci. Rep., 4, 2014, 5031.
9. Fujita, K., Yoshimoto, N., Kato, T., Imada, H., Matsumoto, G., Inakuma, T., Nagata, Y., Miyachi, E., Lycopene inhibits ischemia/reperfusion-induced neuronal apoptosis in gerbil hippocampal tissue. Neurochem. Res. 38 (2013), 461–469.
10. Lei, X., Lei, L., Zhang, Z., Cheng, Y., Neuroprotective effects of lycopene pretreatment on transient global cerebral ischemiareperfusion in rats: the role of the Nrf2/HO1 signaling pathway. Mol. Med. Rep. 13 (2016), 412–418.
11. Clinton, S.K., Lycopene: chemistry, biology, and implications for human health and disease. Nutr. Rev. 56 (1998), 35–51.
12. Tan, C., Xue, J., Abbas, S., Feng, B., Zhang, X., Xia, S., Liposome as a delivery system for carotenoids: comparative antioxidant activity of carotenoids as measured by ferric reducing antioxidant power, DPPH assay and lipid peroxidation. J. Agric. Food Chem. 62 (2014), 6726–6735.
13. Tan, C., Xue, J., Lou, X., Abbas, S., Guan, Y., Feng, B., Zhang, X., Xia, S., Liposomes as delivery systems for carotenoids: comparative studies of loading ability, storage stability and in vitro release. Food Funct. 5 (2014), 1232–1240.
14. Tian, Y.Y., Ge, L., Duan, X.L., Gao, Z.Q., Chang, Y.Z., Lycopene liposomes: lycopene release in vitro and pharmaceutical behaviors and antioxidation in vivo. Yao xue xue bao = Acta Pharm. Sin. 42 (2007), 1107–1111.
15. Carbonell, T., Rama, R., Iron, oxidative stress and early neurological deterioration in ischemic stroke. Curr. Med. Chem. 14 (2007), 857–874.
16. Li, L., Li, Y.W., Zhao, J.Y., Liu, Y.Z., Holscher, C., Quantitative analysis of iron concentration and expression of ferroportin 1 in the cortex and hippocampus of rats induced by cerebral ischemia. J. Clin. Neurosci. 16 (2009), 1466–1472.
17. Won, S.M., Lee, J.H., Park, U.J., Gwag, J., Gwag, B.J., Lee, Y.B., Iron mediates endothelial cell damage and blood-brain barrier opening in the hippocampus after transient forebrain ischemia in rats. Exp. Mol. Med. 43 (2011), 121–128.
18. Hallgren, R., Terent, A., Wide, L., Bergstrom, K., Birgegard, G., Cerebrospinal fluid ferritin in patients with cerebral infarction or bleeding. Acta Neurol. Scand. 61 (1980), 384–392.
19. Davalos, A., Fernandez-Real, J.M., Ricart, W., Soler, S., Molins, A., Planas, E., Genis, D., Iron-related damage in acute ischemic stroke. Stroke 25 (1994), 1543–1546.
20. Loreal, O., Cavey, T., Bardou-Jacquet, E., Guggenbuhl, P., Ropert, M., Brissot, P., Iron, hepcidin, and the metal connection. Front. Pharmacol., 5, 2014, 128.
21. Wang, S.M., Fu, L.J., Duan, X.L., Crooks, D.R., Yu, P., Qian, Z.M., Di, X.J., Li, J., Rouault, T.A., Chang, Y.Z., Role of hepcidin in murine brain iron metabolism. Cell. Mol. Life Sci. 67 (2010), 123–133.
22. Ganz, T., Nemeth, E., Hepcidin and iron homeostasis. Biochim. Biophys. Acta 1823 (2012), 1434–1443.
23. Simonis, G., Mueller, K., Schwarz, P., Wiedemann, S., Adler, G., Strasser, R.H., Kulaksiz, H., The iron-regulatory peptide hepcidin is upregulated in the ischemic and in the remote myocardium after myocardial infarction. Peptides 31 (2010), 1786–1790.
24. Slomka, A., Switonska, M., Zekanowska, E., Hepcidin levels are increased in patients with acute ischemic stroke: preliminary report. J. Stroke Cerebrovasc. Dis.: Off. J. Natl. Stroke Assoc. 24 (2015), 1570–1576.
25. Ding, H., Yan, C.Z., Shi, H., Zhao, Y.S., Chang, S.Y., Yu, P., Wu, W.S., Zhao, C.Y., Chang, Y.Z., Duan, X.L., Hepcidin is involved in iron regulation in the ischemic brain. PLoS One, 6, 2011, e25324.
26. Fatouros, D.G., Antimisiaris, S.G., Effect of amphiphilic drugs on the stability and zeta-potential of their liposome formulations: a study with prednisolone, diazepam, and griseofulvin. J. Colloid Interface Sci. 251 (2002), 271–277.
27. Saleem, S., Zhuang, H., Biswal, S., Christen, Y., Dore, S., Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury. Stroke 39 (2008), 3389–3396.
28. Yang, P.S., Lin, P.Y., Chang, C.C., Yu, M.C., Yen, T.L., Lan, C.C., Jayakumar, T., Yang, C.H., Antrodia camphorata potentiates neuroprotection against cerebral ischemia in rats via downregulation of iNOS/HO-1/Bax and activated caspase-3 and inhibition of hydroxyl radical formation. Evid. Based Complement. Altern. Med., 2015, 2015, 232789.
29. You, L.H., Li, F., Wang, L., Zhao, S.E., Wang, S.M., Zhang, L.L., Zhang, L.H., Duan, X.L., Yu, P., Chang, Y.Z., Brain iron accumulation exacerbates the pathogenesis of MPTP-induced Parkinson's disease. Neuroscience 284C (2014), 234–246.
30. Jeong, S.I., Shin, J.A., Cho, S., Kim, H.W., Lee, J.Y., Kang, J.L., Park, E.M., Resveratrol attenuates peripheral and brain inflammation and reduces ischemic brain injury in aged female mice. Neurobiol. Aging 44 (2016), 74–84.
31. Ge, G., Zhang, Q., Ma, J., Qiao, Z., Huang, J., Cheng, W., Wang, H., Protective effect of Salvia miltiorrhiza aqueous extract on myocardium oxidative injury in ischemic-reperfusion rats. Gene 546 (2014), 97–103.
32. Trilling, M., Le, V.T., Rashidi-Alavijeh, J., Katschinski, B., Scheller, J., Rose-John, S., Androsiac, G.E., Jonjic, S., Poli, V., Pfeffer, K., Hengel, H., “Activated” STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells. J. Immunol. 192 (2014), 447–458.
33. Erta, M., Quintana, A., Hidalgo, J., Interleukin-6, a major cytokine in the central nervous system. Int. J. Biol. Sci. 8 (2012), 1254–1266.
34. Atessahin, A., Ceribasi, A.O., Yilmaz, S., Lycopene, a carotenoid, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rats. Basic Clin. Pharmacol. Toxicol. 100 (2007), 372–376.
35. Agarwal, S., Rao, A.V., Tomato lycopene and its role in human health and chronic diseases. CMAJ: Can. Med. Assoc. J. = J. l′Assoc. Med. Can. 163 (2000), 739–744.
36. Qu, M., Li, L., Chen, C., Li, M., Pei, L., Chu, F., Yang, J., Yu, Z., Wang, D., Zhou, Z., Protective effects of lycopene against amyloid beta-induced neurotoxicity in cultured rat cortical neurons. Neurosci. Lett. 505 (2011), 286–290.
37. Li, W., Wang, G., Lu, X., Jiang, Y., Xu, L., Zhao, X., Lycopene ameliorates renal function in rats with streptozotocin-induced diabetes. Int. J. Clin. Exp. Pathol. 7 (2014), 5008–5015.
38. Yin, Q., Ma, Y., Hong, Y., Hou, X., Chen, J., Shen, C., Sun, M., Dong, S., Pei, J.J., Liu, X., Lycopene attenuates insulin signaling deficits, oxidative stress, neuroinflammation, and cognitive impairment in fructose-drinking insulin resistant rats. Neuropharmacology, 2014.
39. Holzapfel, N.P., Holzapfel, B.M., Champ, S., Feldthusen, J., Clements, J., Hutmacher, D.W., The potential role of lycopene for the prevention and therapy of prostate cancer: from molecular mechanisms to clinical evidence. Int. J. Mol. Sci. 14 (2013), 14620–14646.
40. Kumar, P., Kumar, A., Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism. Food Chem. Toxicol.: Int. J. Publ. Br. Ind. Biol. Res. Assoc. 47 (2009), 2522–2530.
41. Xu, Z., Liu, S., Wang, H., Gao, G., Yu, P., Chang, Y., Encapsulation of iron in liposomes significantly improved the efficiency of iron supplementation in strenuously exercised rats. Biol. Trace Elem. Res. 162 (2014), 181–188.
42. Craparo, E.F., Bondi, M.L., Pitarresi, G., Cavallaro, G., Nanoparticulate systems for drug delivery and targeting to the central nervous system. CNS Neurosci. Ther. 17 (2010), 670–677.
43. Guo, X., Zheng, H., Guo, Y., Wang, Y., Anderson, G.J., Ci, Y., Yu, P., Geng, L., Chang, Y.Z., Nasal delivery of nanoliposome-encapsulated ferric ammonium citrate can increase the iron content of rat brain. J. Nanobiotechnol., 15, 2017, 42.
44. Ferrandi, C., Ballerio, R., Gaillard, P., Giachetti, C., Carboni, S., Vitte, P.A., Gotteland, J.P., Cirillo, R., Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats. Br. J. Pharmacol. 142 (2004), 953–960.
45. Kuwana, T., Mackey, M.R., Perkins, G., Ellisman, M.H., Latterich, M., Schneiter, R., Green, D.R., Newmeyer, D.D., Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111 (2002), 331–342.
46. Sun, L., Fan, H., Yang, L., Shi, L., Liu, Y., Tyrosol prevents ischemia/reperfusion-induced cardiac injury in H9c2 cells: involvement of ROS, Hsp70, JNK and ERK, and apoptosis. Molecules 20 (2015), 3758–3775.
47. Wang, C., Chen, K., Xia, Y., Dai, W., Wang, F., Shen, M., Cheng, P., Wang, J., Lu, J., Zhang, Y., Yang, J., Zhu, R., Zhang, H., Li, J., Zheng, Y., Zhou, Y., Guo, C., N-acetylcysteine attenuates ischemia-reperfusion-induced apoptosis and autophagy in mouse liver via regulation of the ROS/JNK/Bcl-2 pathway. PLoS One, 9, 2014, e108855.
48. Zhang, F., Xing, S., Li, Z., Antagonistic effects of lycopene on cadmium-induced hippocampal dysfunctions in autophagy, calcium homeostatis and redox. Oncotarget 8 (2017), 44720–44731.
49. Davis, S.M., Collier, L.A., Leonardo, C.C., Seifert, H.A., Ajmo, C.T. Jr., Pennypacker, K.R., Leukemia inhibitory factor protects neurons from ischemic damage via upregulation of superoxide dismutase 3. Mol. Neurobiol. 54 (2017), 608–622.
50. Davis, A.S., Zhao, H., Sun, G.H., Sapolsky, R.M., Steinberg, G.K., Gene therapy using SOD1 protects striatal neurons from experimental stroke. Neurosci. Lett. 411 (2007), 32–36.
51. Mikawa, S., Li, Y., Huang, T., Carlson, E., Chen, S., Kondo, T., Murakami, K., E, C., Cerebral infarction is exacerbated in mitochondrial manganese superoxide dismutase (Sod-2) knockout mutant mice after focal cerebral ischemia and reperfusion. Soc. Neurosci. Abstr., 1995.
52. Jiang, Z., Li, C., Arrick, D.M., Yang, S., Baluna, A.E., Sun, H., Role of nitric oxide synthases in early blood-brain barrier disruption following transient focal cerebral ischemia. PLoS One, 9, 2014, e93134.
53. Godinez-Rubi, M., Rojas-Mayorquin, A.E., Ortuno-Sahagun, D., Nitric oxide donors as neuroprotective agents after an ischemic stroke-related inflammatory reaction. Oxid. Med. Cell. Longev., 2013, 2013, 297357.
54. Zhao, Y.S., Zhang, L.H., Yu, P.P., Gou, Y.J., Zhao, J., You, L.H., Wang, Z.Y., Zheng, X., Yan, L.J., Yu, P., Chang, Y.Z., Ceruloplasmin, a potential therapeutic agent for Alzheimer's disease. Antioxid. Redox Signal. 28 (2018), 1323–1337.
55. You, L.H., Yan, C.Z., Zheng, B.J., Ci, Y.Z., Chang, S.Y., Yu, P., Gao, G.F., Li, H.Y., Dong, T.Y., Chang, Y.Z., Astrocyte hepcidin is a key factor in LPS-induced neuronal apoptosis. Cell Death Dis., 8, 2017, e2676.
56. Nemeth, E., Ganz, T., The role of hepcidin in iron metabolism. Acta Haematol. 122 (2009), 78–86.
57. Morgan, E.H., Moos, T., Mechanism and developmental changes in iron transport across the blood-brain barrier. Dev. Neurosci. 24 (2002), 106–113.
58. Bradbury, M.W., Transport of iron in the blood-brain-cerebrospinal fluid system. J. Neurochem. 69 (1997), 443–454.
59. Ge, M., Yao, W., Yuan, D., Zhou, S., Chen, X., Zhang, Y., Li, H., Xia, Z., Hei, Z., Brg1-mediated Nrf2/HO-1 pathway activation alleviates hepatic ischemia-reperfusion injury. Cell Death Dis., 8, 2017, e2841.
60. Sharp, F.R., Zhan, X., Liu, D.Z., Heat shock proteins in the brain: role of Hsp70, Hsp 27, and HO-1 (Hsp32) and their therapeutic potential. Transl. Stroke Res. 4 (2013), 685–692.
61. Broughton, B.R., Reutens, D.C., Sobey, C.G., Apoptotic mechanisms after cerebral ischemia. Stroke 40 (2009), e331–e339.
62. Saijo, K., Winner, B., Carson, C.T., Collier, J.G., Boyer, L., Rosenfeld, M.G., Gage, F.H., Glass, C.K., A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137 (2009), 47–59.
63. Kang, M., Park, K.S., Seo, J.Y., Kim, H., Lycopene inhibits IL-6 expression in cerulein-stimulated pancreatic acinar cells. Genes Nutr. 6 (2011), 117–123.
64. Yuan, L., Geng, L., Ge, L., Yu, P., Duan, X., Chen, J., Chang, Y., Effect of iron liposomes on anemia of inflammation. Int. J. Pharm. 454 (2013), 82–89.
65. Longa, E.Z., Weinstein, P.R., Carlson, S., Cummins, R., Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke; J. Cereb. Circ. 20 (1989), 84–91.
66. Molina-Montes, E., Wark, P.A., Sanchez, M.J., Norat, T., Jakszyn, P., Lujan-Barroso, L., Michaud, D.S., Crowe, F., Allen, N., Khaw, K.T., Wareham, N., Trichopoulou, A., Adarakis, G., Katarachia, H., Skeie, G., Henningsen, M., Broderstad, A.R., Berrino, F., Tumino, R., Palli, D., Mattiello, A., Vineis, P., Amiano, P., Barricarte, A., Huerta, J.M., Duell, E.J., Quiros, J.R., Ye, W., Sund, M., Lindkvist, B., Johansen, D., Overvad, K., Tjonneland, A., Roswall, N., Li, K., Grote, V.A., Steffen, A., Boeing, H., Racine, A., Boutron-Ruault, M.C., Carbonnel, F., Peeters, P.H., Siersema, P.D., Fedirko, V., Jenab, M., Riboli, E., Bueno-de-Mesquita, B., Dietary intake of iron, heme-iron and magnesium and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort. Int. J. Cancer 131 (2012), E1134–E1147.
67. Bederson, J.B., Pitts, L.H., Germano, S.M., Nishimura, M.C., Davis, R.L., Bartkowski, H.M., Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17 (1986), 1304–1308.
68. Wu, W.S., Zhao, Y.S., Shi, Z.H., Chang, S.Y., Nie, G.J., Duan, X.L., Zhao, S.M., Wu, Q., Yang, Z.L., Zhao, B.L., Chang, Y.Z., Mitochondrial ferritin attenuates beta-amyloid-induced neurotoxicity: reduction in oxidative damage through the Erk/P38 mitogen-activated protein kinase pathways. Antioxid. Redox Signal. 18 (2013), 158–169.